Letter by Cerase et al Regarding Article, “Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic”

Cerase, Alfonso; Guazzi, Gianni; Mazzei, Maria Antonietta

doi:10.1161/strokeaha.120.030147

Stroke

2020

DOI: 10.1161/strokeaha.120.030147

|View full text |Cite

Letter by Cerase et al Regarding Article, “Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic”

Alfonso Cerase

Gianni Guazzi

Maria Antonietta Mazzei

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 6 ] However, other issues should be considered in the radiological management of known and suspected COVID-19 patients such as infection control issues related to patient transport to CT suites, infection containment in medical staffs (radiographers, radiologists, and nurses), sanitization of imaging equipment and rooms, and sparing of personal protective equipment. In this scenario, also considering that not all COVID-19 patients experience a complicated lung disease, chest CT could be used “sparingly” and reserved for hospitalized patients with specific clinical indications, as already suggested by ACR recommendations, or in suspected COVID-19 patients requiring both chest imaging and time-based emergency care by priority CT.[ 7 8 ] This case series aims to share in brief an Italian perspective on CXR findings of COVID-19 pneumonia patients from diagnosis until patient recovery.…”

mentioning

confidence: 99%

Novel coronavirus (COVID-19) pneumonia

et al. 2021

View full text Add to dashboard Cite

mentioning

confidence: 99%

Novel coronavirus (COVID-19) pneumonia

et al. 2021

View full text Add to dashboard Cite

Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

et al. 2021

View full text Add to dashboard Cite

Background The spectrum of neurological involvement in COVID-19 is not thoroughly understood. To the best of our knowledge, no systematic review with meta-analysis and a sub-group comparison between severe and non-severe cases has been published. The aim of this study is to assess the frequency of neurological manifestations and complications, identify the neurodiagnostic findings, and compare these aspects between severe and non-severe COVID-19 cases. Methods A systematic search of PubMed, Scopus, EBSCO, Web of Science, and Google Scholar databases was conducted for studies published between the 1st of January 2020 and 22nd of April 2020. In addition, we scanned the bibliography of included studies to identify other potentially eligible studies. The criteria for eligibility included studies published in English language (or translated to English), those involving patients with COVID-19 of all age groups, and reporting neurological findings. Data were extracted from eligible studies. Meta-analyses were conducted using comprehensive meta-analysis software. Random-effects model was used to calculate the pooled percentages and means with their 95% confidence intervals (CIs). Sensitivity analysis was performed to assess the effect of individual studies on the summary estimate. A subgroup analysis was conducted according to severity. The main outcomes of the study were to identify the frequency and nature of neurological manifestations and complications, and the neuro-diagnostic findings in COVID-19 patients. Results 44 articles were included with a pooled sample size of 13,480 patients. The mean age was 50.3 years and 53% were males. The most common neurological manifestations were: Myalgia (22.2, 95% CI, 17.2 to 28.1%), taste impairment (19.6, 95% CI, 3.8 to 60.1%), smell impairment (18.3, 95% CI, 15.4 to 76.2%), headache (12.1, 95% CI, 9.1 to 15.8%), dizziness (11.3, 95% CI, 8.5 to 15.0%), and encephalopathy (9.4, 95% CI, 2.8 to 26.6%). Nearly 2.5% (95% CI, 1 to 6.1%) of patients had acute cerebrovascular diseases (CVD). Myalgia, elevated CK and LDH, and acute CVD were significantly more common in severe cases. Moreover, 20 case reports were assessed qualitatively, and their data presented separately. Conclusions Neurological involvement is common in COVID-19 patients. Early recognition and vigilance of such involvement might impact their overall outcomes.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Letter by Cerase et al Regarding Article, “Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic”

Cited by 2 publications

References 5 publications

Novel coronavirus (COVID-19) pneumonia

Novel coronavirus (COVID-19) pneumonia

Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Contact Info

Product

Resources

About